Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.7%

2 terminated/withdrawn out of 30 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

13%

4 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A
9(69.2%)
Phase 3
4(30.8%)
13Total
N/A(9)
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT07450846Recruiting

Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome

Role: collaborator

NCT04214444Phase 3Completed

Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab

Role: collaborator

NCT06876064Not Yet Recruiting

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Role: collaborator

NCT07195422Not ApplicableNot Yet Recruiting

Evaluation of the Japet.W+ Medical Device for Low Back Pain Management

Role: collaborator

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT05100823Not ApplicableTerminated

Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies

Role: collaborator

NCT03666091Completed

Study and Monitoring of Early Undifferentiated Arthritis

Role: collaborator

NCT06602869Recruiting

Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

Role: collaborator

NCT03905239Not ApplicableRecruiting

A Procalcitonin-based Algorithm in Adhesion-related Small Bowel Obstruction

Role: collaborator

NCT05450770Not ApplicableNot Yet Recruiting

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

Role: collaborator

NCT04366739Phase 3Withdrawn

Repurposing of Chlorpromazine in Covid-19 Treatment

Role: collaborator

NCT06347120Not ApplicableRecruiting

Place of Nasogastric Tube in Uncomplicated Adhesive Small Bowel Obstruction

Role: collaborator

NCT04884048Completed

Multicentric Bone Tumor Imaging Report and Data System

Role: collaborator

NCT05650502Completed

Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin

Role: collaborator

NCT04064489Not ApplicableCompleted

Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.

Role: collaborator

NCT03092024Not ApplicableCompleted

Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study

Role: collaborator

NCT04879316Completed

Energy for Lymphocytes

Role: lead

NCT04499001Unknown

Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs

Role: lead

NCT01942174Phase 3Completed

VACcination In Methotrexate Treated Rheumatoid Arthritis Patients

Role: collaborator

NCT01576705Phase 3Completed

Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children

Role: collaborator